Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ABBVIE

  • FDA Approval
  • Sept. 19, 2025, 16:06 UTC
  • 37
  • 0 comments

FDA approve BRIMONIDINE TARTRATE

Comment Full text

RISING

  • FDA Approval
  • Sept. 19, 2025, 16:06 UTC
  • 43
  • 0 comments

FDA approve ATROPINE SULFATE

Comment Full text

ABBVIE

  • FDA Approval
  • Sept. 19, 2025, 16:06 UTC
  • 47
  • 0 comments

FDA approve BRIMONIDINE TARTRATE

Comment Full text

RISING

  • FDA Approval
  • Sept. 19, 2025, 15:35 UTC
  • 43
  • 0 comments

FDA approve AZELASTINE HYDROCHLORIDE

Comment Full text

ALLERGAN

  • FDA Approval
  • Sept. 19, 2025, 15:35 UTC
  • 41
  • 0 comments

FDA approve BRIMONIDINE TARTRATE

Comment Full text

ABBVIE

  • FDA Approval
  • Sept. 19, 2025, 15:35 UTC
  • 45
  • 0 comments

FDA approve KETOROLAC TROMETHAMINE

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • Sept. 19, 2025, 13:56 UTC
  • 44
  • 0 comments

FDA approve TOFACITINIB

Comment Full text

WUHAN HUMANWELL LIKANG PHARMACEUTICAL CO. LTD.

  • FDA Approval
  • Sept. 19, 2025, 13:56 UTC
  • 44
  • 0 comments

FDA approve OXCARBAZEPINE

Comment Full text

ORBICULAR PHARMACEUTICAL TECHNOLOGIES PVT LTD

  • FDA Approval
  • Sept. 19, 2025, 13:40 UTC
  • 37
  • 0 comments

FDA approve LIRAGLUTIDE

Comment Full text

MACLEODS PHARMACEUTICALS LTD

  • FDA Approval
  • Sept. 19, 2025, 13:40 UTC
  • 40
  • 0 comments

FDA approve ABACAVIR, DOLUTEGRAVIR, LAMIVUDINE

Comment Full text
  • Previous
  • 35
  • 36
  • 37
  • 38
  • 39
  • Next

Search

News categories

  • Technical Exchange News(10582)
  • Event(1959)
  • SEC News(183814)
  • FDA Approval(9822)
  • Company Report(721)
  • Business News(121987)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin